Stomach cancer, also known as gastric cancer, is the fourth-highest cause of cancer deaths worldwide, and 17th-most common ...

What if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable populations? A ...

Stomach cancer, also known as gastric cancer, can be a stealthy foe, often developing silently without obvious symptoms in ...

The Moonshot program was the largest, organized effort by the U.S. government to find cancer cures. Congress voted it down.

A Chinese woman's routine medical exam revealed a hidden testicle, prompting doctors to diagnose her with a rare genetic ...

Global HER2 Positive Gastric Cancer Industry is estimated at US$ 1261.8 Million in 2023 and US$ 1779.8 Million by 2033, at a ...

Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with ...

For certain patients with HER2-positive gastric cancers, a Keytruda treatment combination has shown promising survival outcomes.

Merck Research Laboratories' global clinical development oncology head and senior vice-president Dr Marjorie Green said: ...

Exeliom is running three Phase II trials of the candidate in three oncology indications but will focus on the gastric cancer ...

The university’s Hereditary Diffuse Gastric Cancer Research Group today received the Te Pūiaki Putaiao Matua a Te Pirimia ...

While the disease — most commonly diagnosed in older adults — remains the second-leading cause of death in the United States, ...